azacrin has been researched along with 1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione in 1 studies
| Studies (azacrin) | Trials (azacrin) | Recent Studies (post-2010) (azacrin) | Studies (1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione) | Trials (1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione) | Recent Studies (post-2010) (1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 12 | 0 | 4 |
| Protein | Taxonomy | azacrin (IC50) | 1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione (IC50) |
|---|---|---|---|
| MPI protein | Homo sapiens (human) | 6.088 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 0.0375 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 0.0256 | |
| sphingosine 1-phosphate receptor 2 | Homo sapiens (human) | 1.338 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 0.0256 | |
| mothers against decapentaplegic homolog 3 isoform 1 | Homo sapiens (human) | 0.038 | |
| cysteine protease ATG4B isoform a | Homo sapiens (human) | 3.73 | |
| tyrosine-protein phosphatase non-receptor type 22 isoform 1 | Homo sapiens (human) | 1.24 | |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | 1.24 | |
| RNA-editing ligase 1, mitochondrial | Trypanosoma brucei brucei | 0.4108 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
1 other study(ies) available for azacrin and 1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione
| Article | Year |
|---|---|
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |